Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
González Carro
P
P
Gastroenterology Department, Hospital General La Mancha Centro, Alcazar de San Juan, Spain. pesagoca@gmail.com
Pérez Roldán
F
F
Roncero García Escribano
O
O
Lafuente
R
R
Legaz Huidobro
M L
ML
Amigo Echenagusía
A
A
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003424:Crohn Disease / Q000188:drug therapy / Q000628:therapy*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000069285:Infliximab; D007937:Leukapheresis; D019804:Mesalamine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D019804:Mesalamine; D000069285:Infliximab; D001379:Azathioprine; D011241:Prednisone